Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb 9;28(18):e49.
doi: 10.1093/eurjpc/zwaa059.

Fatty liver disease in obese patients with COVID-19: a tale of two pandemics?

Seng Lim Yeoh  1   2 , Gerard Thomas Flaherty  1   2
Affiliations
Comment

Fatty liver disease in obese patients with COVID-19: a tale of two pandemics?

Seng Lim Yeoh et al. Eur J Prev Cardiol. .
No abstract available

PubMed Disclaimer

Comment on

  • Cardiovascular disease and COVID-19: les liaisons dangereuses.
    Barison A, Aimo A, Castiglione V, Arzilli C, Lupón J, Codina P, Santiago-Vacas E, Cediel G, Emdin M, Bayes-Genis A. Barison A, et al. Eur J Prev Cardiol. 2020 Jul;27(10):1017-1025. doi: 10.1177/2047487320924501. Epub 2020 May 11. Eur J Prev Cardiol. 2020. PMID: 32391719 Free PMC article. Review.

References

    1. Barison A, Aimo A, Castiglione V, Arzilli C, Lupón J, Codina P, Santiago-Vacas E, Cediel G, Emdin M, Bayes-Genis A. Cardiovascular disease and COVID-19: les liaisons dangereuses. Eur J Prev Cardiol 2020;27:1017–1025. - PMC - PubMed
    1. Janssen A, Grobbee DE, Dendale P. Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease. Eur J Prev Cardiol 2020;27:1059–1063. - PubMed
    1. Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review. J Am Coll Cardiol 2019;73:948–963. - PubMed
    1. Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, Sulaiman LK. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vacc 2020, 1-13. doi: 10.1186/s40794-020-00118-y. - PMC - PubMed
    1. Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, Ma HL, Chen YP, Liu WY, George J, Zheng M-H. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism 2020;108:154244. - PMC - PubMed